Anticancer effects of 7,8-dihydromethysticin in human leukemia cells are mediated via cell-cycle dysregulation, inhibition of cell migration and invasion and targeting JAK/STAT pathway
The main focus of this research work was to study the anti-cancer properties of 7,8-dihydromethysticin against HL-60 leukemia cells. Investigations were also performed to check its impact on the phases of the cell cycle, cell migration and invasion, JAK/STAT signalling pathway and intracellular mito...
Saved in:
Main Authors: | Xiao Yi, Deng Taoran, Jiang Lijun, Wang Di |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2021-12-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2021-0037 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Laboratory analysis of 124 chronic lymphocytic leukemia cases: Single center study
by: Shams Salah Mahdi, et al.
Published: (2024-12-01) -
Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II
by: Lokman Varisli, et al.
Published: (2025-01-01) -
Pharmacokinetics of 7,8-dihydroxyflavone in neonatal mice with hypoxia-ischemia related brain injury
by: Sin Yin Lim, et al.
Published: (2025-01-01) -
Pathogenicity role of human herpesvirus-8 in patients with acute myeloid leukemia
by: Zahraa Ali Abdullah, et al.
Published: (2024-12-01) -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Ugo Testa, et al.
Published: (2024-04-01)